Pharmaceutical Industry

Page 74 of 100

Fortune Global Forum 2015
Leadership

Meet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals

By
May 10, 2016
New England Towns Struggle With Opioid And Heroin Epidemic
Health

OxyContin’s 12-Hour Dosing Claim Attacked In Massive Investigation

By
May 6, 2016
Fortune Brainstorm Tech 2015

Diabetes ‘Unicorn’ Intarcia Hits Major Milestone

By
May 6, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck CEO: We’re on the Hunt for Deals in 2016

By
May 6, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health

Valeant Says it Has a New Way to Ensure it Doesn’t Price Gouge So Much

By
May 6, 2016
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
Health

Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger

By
May 6, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
Health

Now It’s Pfizer That Wants to Buy Cancer Drug Maker Medivation

By
May 4, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By
May 3, 2016
172646513
Health

U.S. Approves First Drug for Psychosis Linked to Parkinson’s

By
April 30, 2016
493534821
Health

Big Pharma Under Pressure to Pay For Drug Take-Back Programs

By
April 30, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Finance

AbbVie Buying Cancer Drug Startup Stemcentrx for $10.2 Billion

By
April 28, 2016
Sanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker
Health

Sanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker

By
April 28, 2016
Squawk Box - Season 20
Finance

Bill Ackman: Valeant’s Drug Price Hikes Hurt America

By
April 27, 2016
547016547
Health

Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop

By
April 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership

Valeant CEO to Tell Senate Jacking Up Heart Drug Prices Was a ‘Mistake’

By
April 27, 2016

Most Popular